About University of Texas, M. D. Anderson Cancer Center:
The University of Texas MD Anderson Cancer Center (MD Anderson) was established by the Texas State Legislature in 1941and is a free-standing, degree-granting health institution within The University of Texas System. Mission areas include patient care, research, education, and prevention. In 1971 MD Anderson became one of the nation’s first NCI-designated comprehensive cancer centers. MD Anderson’s strength lies in its ability to rapidly translate scientific knowledge into improved cancer therapies and prevention strategies.
MD Anderson houses one of the largest, most developed cancer prevention programs in the nation, conducting research to assess and manage cancer risk through early detection, genetic counseling and clinical interventions, and implementing prevention programs that include genetic testing, chemoprevention, behavioral and nutritional counseling. Translational goals are to develop and deliver comprehensive evidence-based strategies to achieve a measurable lasting reduction in the cancer burden, especially among the underserved.
Cancer is the singular focus for MD Anderson’s workforce of more than 19,000 employees with over 1,600 full-time faculty scholars who lead the largest number of NCI-funded grant programs and clinical trials of any institution in the nation. More than 6,500 trainees take part each year in educational programs, including advanced degrees at the Graduate School of Biomedical Science covering training from Cancer Biology to Clinical and Translational Science and bachelor’s degrees in allied health disciplines. MD Anderson invested approximately $700 million in research (FY14) which is anticipated to increase with our cancer Moon Shots Program.